Epidemiology of Vancomycin-resistant Enterococci in Canadian Hospitals (CANWARD Study, 2007 to 2013)

Overview

Journal Antimicrob Agents Chemother

Publisher American Society for Microbiology

Specialty Pharmacology

Date 2015 Apr 22

PMID 25896693

Citations 16

Authors

P J Simner

H Adam

M Baxter

M McCracken

G Golding

J A Karlowsky

K Nichol

P Lagace-Wiens

M W Gilmour

D J Hoban

G G Zhanel

Affiliations

Soon will be listed here.

Abstract

Of 1,927 Enterococcus species isolates collected across Canada from 2007 to 2013, 80 (4.2%) were identified as vancomycin-resistant enterococci (VRE). VRE infections during this time tripled in Canadian hospitals, from 1.8% to 6.0% (P = 0.03). All VRE were Enterococcus faecium, with 90% possessing vanA. The prevalence of vanB decreased from 37.5% in 2007 to 0% in 2013 (P < 0.05). The VRE were multidrug resistant, but 70.6%, 86.3%, and 100% were susceptible to doxycycline, linezolid, and daptomycin, respectively.

Citing Articles

Sentinel Surveillance reveals phylogenetic diversity and detection of linear plasmids harboring and among enterococci collected in the United States.

Kent A, Spicer L, Campbell D, Breaker E, McAllister G, Ewing T Antimicrob Agents Chemother. 2024; 68(11):e0059124.

PMID: 39404260 PMC: 11539240. DOI: 10.1128/aac.00591-24.

Antimicrobial resistance in Enterococcus isolated from western Canadian cow-calf herds.

Fossen J, Campbell J, Gow S, Erickson N, Waldner C BMC Vet Res. 2024; 20(1):6.

PMID: 38172772 PMC: 10763084. DOI: 10.1186/s12917-023-03843-6.

Antimicrobial Susceptibility Profile of Pathogenic and Commensal Bacteria Recovered from Cattle and Goat Farms.

Mukuna W, Aniume T, Pokharel B, Khwatenge C, Basnet A, Kilonzo-Nthenge A Antibiotics (Basel). 2023; 12(2).

PMID: 36830330 PMC: 9952079. DOI: 10.3390/antibiotics12020420.

Distinguishing Clinical Strains and Resistance to Vancomycin Using a Simple In-House Screening Test.

Saenhom N, Boueroy P, Chopjitt P, Hatrongjit R, Kerdsin A Antibiotics (Basel). 2022; 11(3).

PMID: 35326750 PMC: 8944677. DOI: 10.3390/antibiotics11030286.

Molecular Epidemiology of Vancomycin-Resistant Enterococci Bloodstream Infections in Germany: A Population-Based Prospective Longitudinal Study.

Correa-Martinez C, Jurke A, Schmitz J, Schaumburg F, Kampmeier S, Mellmann A Microorganisms. 2022; 10(1).

PMID: 35056579 PMC: 8777844. DOI: 10.3390/microorganisms10010130.

References

Ramsey A, Zilberberg M . Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the United States, 2000-2006. Infect Control Hosp Epidemiol. 2009; 30(2):184-6. DOI: 10.1086/593956. View

Jia X, Pang F, Chen J, Jiang L . Prevalence and clinical distribution of multidrug-resistant bacteria (3537 isolates) in a tertiary Chinese hospital (January 2012-December 2013). Pathol Biol (Paris). 2015; 63(1):21-3. DOI: 10.1016/j.patbio.2014.12.002. View

Kang M, Xie Y, He C, Chen Z, Guo L, Yang Q . Molecular characteristics of vancomycin-resistant Enterococcus faecium from a tertiary care hospital in Chengdu, China: molecular characteristics of VRE in China. Eur J Clin Microbiol Infect Dis. 2014; 33(6):933-9. DOI: 10.1007/s10096-013-2029-z. View

Boyd D, Willey B, Fawcett D, Gillani N, Mulvey M . Molecular characterization of Enterococcus faecalis N06-0364 with low-level vancomycin resistance harboring a novel D-Ala-D-Ser gene cluster, vanL. Antimicrob Agents Chemother. 2008; 52(7):2667-72. PMC: 2443935. DOI: 10.1128/AAC.01516-07. View

Deshpande L, Fritsche T, Moet G, Biedenbach D, Jones R . Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis. 2007; 58(2):163-70. DOI: 10.1016/j.diagmicrobio.2006.12.022. View

Zhanel G, Decorby M, Nichol K, Baudry P, Karlowsky J, Lagace-Wiens P . Characterization of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci and extended-spectrum beta-lactamase-producing Escherichia coli in intensive care units in Canada: Results of the Canadian National Intensive Care Unit.... Can J Infect Dis Med Microbiol. 2009; 19(3):243-9. PMC: 2605872. DOI: 10.1155/2008/714846. View

Arias C, Contreras G, Murray B . Management of multidrug-resistant enterococcal infections. Clin Microbiol Infect. 2010; 16(6):555-62. PMC: 3686902. DOI: 10.1111/j.1469-0691.2010.03214.x. View

Zhanel G, Adam H, Baxter M, Fuller J, Nichol K, Denisuik A . Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study. J Antimicrob Chemother. 2013; 68 Suppl 1:i7-22. DOI: 10.1093/jac/dkt022. View

McCracken M, Wong A, Mitchell R, Gravel D, Conly J, Embil J . Molecular epidemiology of vancomycin-resistant enterococcal bacteraemia: results from the Canadian Nosocomial Infection Surveillance Program, 1999-2009. J Antimicrob Chemother. 2013; 68(7):1505-9. DOI: 10.1093/jac/dkt054. View

10.

Denkinger C, Grant A, Denkinger M, Gautam S, DAgata E . Increased multi-drug resistance among the elderly on admission to the hospital--a 12-year surveillance study. Arch Gerontol Geriatr. 2012; 56(1):227-30. DOI: 10.1016/j.archger.2012.05.006. View

11.

Reik R, Tenover F, Klein E, McDonald L . The burden of vancomycin-resistant enterococcal infections in US hospitals, 2003 to 2004. Diagn Microbiol Infect Dis. 2008; 62(1):81-5. DOI: 10.1016/j.diagmicrobio.2008.04.013. View

12.

Ofner-Agostini M, Conly J, Paton S, Kureishi A, Nicolle L, Mulvey M . Vancomycin-resistant enterococci (VRE) in Canada - Results of the Canadian Nosocomial Infection Surveillance Program 1996 VRE point prevalence surveillance project. Can J Infect Dis. 2012; 8(2):73-8. PMC: 3327345. DOI: 10.1155/1997/297038. View

13.

Lu C, Chuang Y, Chang H, Chen Y, Wang J, Chang S . Microbiological and clinical characteristics of vancomycin-resistant Enterococcus faecium bacteraemia in Taiwan: implication of sequence type for prognosis. J Antimicrob Chemother. 2012; 67(9):2243-9. DOI: 10.1093/jac/dks181. View